Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21Cip1

被引：6
|
作者：
Jang, TJ
Park, JH
Cho, MY
Kim, JR
机构：
[1] Donnguk Univ, Coll Med, Dept Pathol, Kyongbuk 780714, South Korea
[2] Yonsei Univ, Wonju Coll Med, Dept Pathol, Kangwon Do 220701, South Korea
来源：
CANCER LETTERS | 2001年 / 170卷 / 02期
关键词：
mammary tumor; cyclin D1; cyclin E; p21(Cip1); tamoxifen;
D O I：
10.1016/S0304-3835(01)00593-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We studied the effects of tamoxifen (TAM) on the growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumor and the expression of cyclin DI, cyclin E, p21(Cip1), and estrogen receptors (ER) by performing immunohistochemistry and Western blot analysis. When tumor size reached between 10 and 15 nim. in the largest dimension, the rats were divided into a DMBA-control group and a DMBA-TAM group. The administration of TAM markedly decreased the tumor development and showed decreased expression of bromodeoxyuridine, cyclin D1, cyclin E, and p21(Cip1) when compared with those of the DMBA-control group; however, a few tumors showed progressive growth in spite of TAM treatment. These tumors had decreased expression of ER. This study suggests that TAM suppresses tumor development through the down-expression of cyclin D1 and cyclin E. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：109 / 116
页数：8
相关论文
共 50 条
  • [21] The protein SET regulates the inhibitory effect of p21Cip1 on cyclin E-cyclin-dependent kinase 2 activity
    Estanyol, Josep Maria
    Jaumot, Montserrat
    Casanovas, Oriol
    Rodriguez-Vilarrupla, Aina
    Agell, Neus
    Bachs, Oriol
    Journal of Biological Chemistry, 274 (46): : 33161 - 33165
  • [22] Cyclin D1 and p21 assesment at tamoxifen resistant breast cancer
    Cayirci, Mine
    Karadayi, Nimet
    Guel, Aylin
    Yavuzer, Dilek
    VIRCHOWS ARCHIV, 2008, 452 : S136 - S136
  • [23] The protein SET regulates the inhibitory effect of p21Cip1 cyclin E-cyclin-dependent kinase 2 activity
    Estanyol, JM
    Jaumot, M
    Casanovas, O
    Rodriguez-Vilarrupla, A
    Agell, N
    Bachs, O
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) : 33161 - 33165
  • [24] IMMUNOHISTOCHEMICAL PATTERN OF PROTEIN P21, CYCLIN D1 AND CYCLIN E IN ENDOMETRIAL HYPERPLASIA
    Brucka, Aleksandra
    Bartczak, Piotr
    Ratynska, Marzena
    Sporny, Stanislaw
    POLISH JOURNAL OF PATHOLOGY, 2009, 60 (01) : 19 - 25
  • [25] P21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7
    Noya, F
    Chien, WM
    Broker, TR
    Chow, LT
    JOURNAL OF VIROLOGY, 2001, 75 (13) : 6121 - 6134
  • [26] Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells
    Kathryn Balmanno
    Simon J Cook
    Oncogene, 1999, 18 : 3085 - 3097
  • [27] Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells
    Balmanno, K
    Cook, SJ
    ONCOGENE, 1999, 18 (20) : 3085 - 3097
  • [28] Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer
    Liukkonen, T
    Lipponen, P
    Raitanen, M
    Kaasinen, E
    Ala-Opas, M
    Rajala, P
    Kosma, VM
    UROLOGICAL RESEARCH, 2000, 28 (05): : 285 - 292
  • [29] Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer
    T. Liukkonen
    P. Lipponen
    M. Raitanen
    E. Kaasinen
    M. Ala-Opas
    P. Rajala
    V.-M. Kosma
    Urological Research, 2000, 28 : 285 - 292
  • [30] Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis
    Wang, QS
    Sabourin, CLK
    Wang, H
    Stoner, GD
    CARCINOGENESIS, 1996, 17 (08) : 1583 - 1588
12345